Stocks Health care PROK

NASDAQ · Health care

Prokidney Corp. (PROK)

Prokidney Corp. brought in $818K of revenue over the twelve months to June 30, 2026, up 55.2% from a year earlier. It posted a net loss of $84.2M. In fiscal 2025 capital spending exceeded operating cash flow by $135.3M. At June 30, 2026 it held $74.9M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 10, 2026.

What Prokidney Corp. does

Prokidney Corp. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker PROK.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Where PROK ranks in Health care

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Prokidney Corp. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. August 12, 2026
   Passive stake changed SCHEDULE 13G/A
2. August 10, 2026
   Quarterly results 8-K
3. August 10, 2026
   Quarterly report 10-Q · period to June 30, 2026
4. May 29, 2026
   Shareholder vote results 8-K
5. May 15, 2026
   Quarterly results 8-K
6. May 15, 2026
   Quarterly report 10-Q · period to March 31, 2026
7. April 30, 2026
   Activist stake changed SCHEDULE 13D/A
8. April 17, 2026
   Annual report to shareholders ARS
9. April 17, 2026
   Additional proxy material DEFA14A
10. April 17, 2026
    Proxy statement DEF 14A

Recent insider filings (Forms 3, 4 and 144): 10, the latest on August 20, 2026. Insider transactions on SEC

Insider trades

What the people running Prokidney Corp. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

All insider filings on SEC.gov · Where insiders are buying across the market

All filings on SEC EDGAR

Questions about PROK

What does Prokidney Corp. do?

Prokidney Corp. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker PROK.

Is Prokidney Corp. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $84.2M on revenue of $818K.

How much revenue does Prokidney Corp. make?

Over the twelve months to June 30, 2026 Prokidney Corp. reported revenue of $818K. That is 55.2% more than a year earlier.

When did Prokidney Corp. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 10, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from August 20, 2026.

Similar companies

Compare PROK with

Compare PROK with any company

Follow PROK

Get an email when Prokidney Corp. files with the SEC: results, executive changes, material agreements and annual reports.

Follow PROK: get an email when it files

Where the numbers come from

Financial figures are the values Prokidney Corp. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.